Central core disease: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|A congenital myopathy characterized by muscle weakness}} | ||
| | {{Medical resources}} | ||
'''Central core disease''' (CCD) is a rare [[congenital myopathy]] that primarily affects [[skeletal muscle]]s, leading to muscle weakness and other associated symptoms. It is named for the characteristic appearance of "cores" or areas of disorganized structure within the muscle fibers, which can be observed under a microscope. | |||
==Presentation== | |||
Individuals with central core disease typically present with [[muscle weakness]] that is most pronounced in the [[proximal muscles]] of the body, such as those in the [[hips]], [[thighs]], and [[shoulders]]. This weakness can lead to difficulties with [[motor skills]] such as walking, running, and climbing stairs. In some cases, affected individuals may also experience [[hypotonia]], or decreased muscle tone, which can contribute to [[delayed motor development]] in infants and young children. | |||
==Genetics== | |||
Central core disease is most commonly inherited in an [[autosomal dominant]] pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is often associated with mutations in the [[RYR1 gene]], which encodes the ryanodine receptor 1, a protein that plays a critical role in [[calcium ion]] release from the [[sarcoplasmic reticulum]] in muscle cells. This release is essential for muscle contraction. | |||
==Pathophysiology== | ==Pathophysiology== | ||
The "cores" seen in muscle biopsies of individuals with central core disease are areas where the normal structure of the muscle fiber is disrupted. These cores lack mitochondria and other essential components, leading to impaired muscle function. The exact mechanism by which RYR1 mutations lead to core formation is not fully understood, but it is believed to involve abnormal calcium handling within the muscle cells. | |||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of central core disease is typically based on a combination of clinical evaluation, [[muscle biopsy]], and genetic testing. Muscle biopsy reveals the characteristic central cores, while genetic testing can identify mutations in the RYR1 gene. [[Electromyography]] (EMG) and other tests may also be used to assess muscle function. | |||
[[ | ==Management== | ||
There is currently no cure for central core disease, and treatment is primarily supportive. [[Physical therapy]] and [[occupational therapy]] can help improve muscle strength and function, while [[orthopedic interventions]] may be necessary to address skeletal abnormalities. Individuals with central core disease should be monitored for potential complications, such as [[malignant hyperthermia]], a life-threatening reaction to certain anesthetics. | |||
== | ==Prognosis== | ||
The prognosis for individuals with central core disease varies widely. Some individuals experience only mild muscle weakness and lead relatively normal lives, while others may have more significant impairments. The risk of malignant hyperthermia is a serious concern and requires careful management during surgical procedures. | |||
== | ==Related pages== | ||
* [[Congenital myopathy]] | |||
* [[RYR1 gene]] | |||
* [[Malignant hyperthermia]] | |||
* [[Muscle biopsy]] | |||
[[Category:Congenital disorders]] | |||
[[Category: | [[Category:Muscular disorders]] | ||
[[Category: | [[Category:Genetic disorders]] | ||
Revision as of 19:19, 22 March 2025
A congenital myopathy characterized by muscle weakness
Central core disease (CCD) is a rare congenital myopathy that primarily affects skeletal muscles, leading to muscle weakness and other associated symptoms. It is named for the characteristic appearance of "cores" or areas of disorganized structure within the muscle fibers, which can be observed under a microscope.
Presentation
Individuals with central core disease typically present with muscle weakness that is most pronounced in the proximal muscles of the body, such as those in the hips, thighs, and shoulders. This weakness can lead to difficulties with motor skills such as walking, running, and climbing stairs. In some cases, affected individuals may also experience hypotonia, or decreased muscle tone, which can contribute to delayed motor development in infants and young children.
Genetics
Central core disease is most commonly inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is often associated with mutations in the RYR1 gene, which encodes the ryanodine receptor 1, a protein that plays a critical role in calcium ion release from the sarcoplasmic reticulum in muscle cells. This release is essential for muscle contraction.
Pathophysiology
The "cores" seen in muscle biopsies of individuals with central core disease are areas where the normal structure of the muscle fiber is disrupted. These cores lack mitochondria and other essential components, leading to impaired muscle function. The exact mechanism by which RYR1 mutations lead to core formation is not fully understood, but it is believed to involve abnormal calcium handling within the muscle cells.
Diagnosis
Diagnosis of central core disease is typically based on a combination of clinical evaluation, muscle biopsy, and genetic testing. Muscle biopsy reveals the characteristic central cores, while genetic testing can identify mutations in the RYR1 gene. Electromyography (EMG) and other tests may also be used to assess muscle function.
Management
There is currently no cure for central core disease, and treatment is primarily supportive. Physical therapy and occupational therapy can help improve muscle strength and function, while orthopedic interventions may be necessary to address skeletal abnormalities. Individuals with central core disease should be monitored for potential complications, such as malignant hyperthermia, a life-threatening reaction to certain anesthetics.
Prognosis
The prognosis for individuals with central core disease varies widely. Some individuals experience only mild muscle weakness and lead relatively normal lives, while others may have more significant impairments. The risk of malignant hyperthermia is a serious concern and requires careful management during surgical procedures.
